BetterLife Pharma Names Peter Goadsby Co-Chair of Scientific Advisory Board

Bitget2026/10/14 16:41

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

BetterLife Pharma formed a scientific advisory board, appointing Professor Peter Goadsby co-chair.
The board will guide BETR-001 clinical development for chronic cluster headache and chronic migraine.
Goadsby previously held faculty positions at University College London and the University of California, San Francisco.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BetterLife Pharma Inc. published the original content used to generate this news brief on October 14, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

BetterLife Pharma Names Peter Goadsby Co-Chair of Scientific Advisory Board

You may also like

Crypto prices